Breaking the vicious cycle: Triple therapy strengthens nasal mucosal barrier function
Treatment with the CFTR modulators elexacaftor, tezacaftor and ivacaftor improves the innate defenses in the nasal mucosa and reduces inflammatory reactions in children with cystic fibrosis. This was shown by researchers at the Charité -...